According to the research report titled ‘Global Anthrax Vaccine Market size study by Vaccine Type (Cell-Free PA Vaccine and Live Attenuated Vaccine), Application (Animal Use and Human Use), Distribution Channel (Hospitals, Pharmacies, and Other Distribution Channels), Regional Forecasts 2021-2027’, available with MarketStudyReport, worldwide anthrax vaccine market is anticipated to observe a growth rate exceeding 7.85% during the forecast timeframe of 2021-2027.
 

As per the findings of the report, surging demand for undercooked/raw meat, as well as rising number of incidences of anthrax are majorly driving the global anthrax vaccine market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4285248/
 

Moreover, technological advancements are favorably impacting the market outlook. For instance, Dr. Jamie Benn Felix and Cook Wildlife Lab team in collaboration with Texas A&M University College of Veterinary Medicine & Biomedical Sciences launched a preliminary trial for the first oral anthrax vaccination for cattle in August 2020.
 

Despite the positive outlook, high-priced vaccines may hamper the market expansion over the analysis timespan.
 

For the uninformed, spore-forming bacteria Bacillus anthracis causes anthrax, which is a fatal condition. Humans can be infected with anthrax bacterium through direct or indirect contact with infected animals. To prevent anthrax, a three-dose program of immunizations is required which comes in two categories, cell-free protective agent (PA) and live anthrax vaccines.
 

From regional perspective, as per the report, key geographies considered for assessing the worldwide anthrax vaccine market size and scope are North America (U.S., Canada), Europe (UK, Germany, Spain, France, Italy), Asia Pacific (Japan, China, South Korea, India, Australia), and Latin America (Mexico and Brazil).
 

Among these regions, North America has the largest market share across the world. Moreover, Agricultural Economic Insights (AEI) study claims that meat consumption, which is the primarily cause of lethal disease, grew considerably from the year 1970 to 2020, in United States.
 

Meanwhile, European anthrax vaccine market is rapidly expanding owing to escalating number of cases of anthrax, particularly in United Kingdom and Germany.  Whereas, Asia Pacific and Latin American markets are projected to expand significantly due to modernized health care infrastructure, strengthening economy, surging insurance payers, and growing awareness among the people in developing economies.
 

Considering the competitive landscape, Merck & Co. Inc., Altimmune (PharmAthene Inc.), Zoetis Inc., Godrej Agrovet Ltd., Biogenesis Bago SA, Indian Immunologicals Ltd., Colondo Serum Co., and Emergent BioSolutions Inc. are among the major companies influencing the anthrax vaccine industry trends.